Pharma Stocks
-
Is This ‘Boring’ Cancer Stock the Next Viral Money Pl
Everyone’s sleeping on Telix Pharmaceuticals Ltd, but the numbers are not. Here is the real talk on whether this under?the?radar…
Read More » -
Renee Gala Outlines Jazz Pharmaceuticals Vision And Pipeline Priorities For Investors
Jazz Pharmaceuticals (NasdaqGS:JAZZ) CEO Renee Gala has outlined a refreshed long-term vision for growth and research focus. The update centers…
Read More » -
Sun Pharma: What should investors do?
With two innovative medicine launches underway in the US and a third expected in the next one year along with…
Read More » -
Royalty Pharma (RPRX) Valuation Check After Strong Portfolio Growth And 2026 Guidance Update
Royalty Pharma (RPRX) shares are in focus after the company reported double digit portfolio receipts growth, better than expected adjusted…
Read More » -
Be Sure To Check Out Bliss GVS Pharma Limited (NSE:BLISSGVS) Before It Goes Ex-Dividend
Bliss GVS Pharma Limited (NSE:BLISSGVS) stock is about to trade ex-dividend in three days. The ex-dividend date is usually set…
Read More » -
Is Viatris (VTRS) Quietly Repositioning Its Deal-Making Strategy With a New Chief Legal Officer?
Viatris Inc. recently appointed Matthew J. Maletta as Chief Legal Officer, effective February 9, 2026, bringing nearly 30 years of…
Read More » -
Assessing Avadel Pharmaceuticals (AVDL) Valuation As Shares Hover Near US$21 After Strong One Year Return
Avadel Pharmaceuticals (AVDL) has drawn investor attention after recent trading left the shares around $21.64, prompting fresh interest in how…
Read More » -
Natco Pharma Shares Slump 2% as the USFDA Issued 7 Observations
February 13, 2026February 13, 2026 Shares of Natco Pharma Ltd…
Read More » -
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares
OKYO Pharma LTD LONDON and NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage…
Read More » -
OKYO Pharma Announces Public Offering of Ordinary Shares
OKYO Pharma LTD LONDON and NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical…
Read More »